Table 1 Patient characteristics of hyperhaploid PCM cohort

From: Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations

Case

Site

Sex

Age (years)

Karyotype

FISH results

TP53 mutation

Time to death (months)

1

Mayo

F

39

33,X,add(1)(p11), +3, +del(5)(q13q35), +add(6)(p23), +add(7)(p22),add(8)(q22), +9, +11, +14, +15, +16, +18,add(20)(q11.2)[1]/46,XX[29]

Monosomies 13, 17; three copies of CCND1

NT

41.3

2

Mayo

M

54

34,X,dup(1)(q21q32), +del(3)(q12), +5, +7, +8, +9, +11, +14, +15, +18, +19, +21[1]/54~69,idemx2[cp18]/46,XY[1]

Monosomies 13, 17; 5’IGH deletion; near-tetraploid

p.Arg196*

4

3

Mayo

M

71

32,X, +3, +5, +7, +9, +add(10)(q24), +15, +18, +22, +mar[1]/46,XY[19]

Monosomies 13, 14, 17

NT

12.9

4

HHC

F

61

60~62,XX, +3, +3, +6, +7, +7, +8, +9, +9, +11, +11, +11, +15, +15, +16,−18,−18, +19, +19, +20, +2mar[cp2]/46,XX[18]

Monosomies 1, 8, 13, 14, 17

NT

1.4

5

Mayo

M

49

31~32,del(X)(q13), +add(3)(p21), +add(7)(p22), +add(9)(q11), +11, +15,−18, +21, +2mar[cp14]/ 61~62,idemx2, +2mar[cp6]

Not performed

NT

0.9

6

Mayo

F

52

30,X, +3, +7, +9, +11, +18, +add(19)(p13.3), +21[3]/51~54,idemx2,−3,−4,−7,−18,−add(19)(p13.3),−22, +2~3mar[cp8]

Not performed

None

30.1

7

Mayo

F

55

32~34,X, +3, +5, +7, +9, +add(11)(p15),add(14)(p11.2), +18, +19, +21, +r, +1~2mar[cp7]/66,idemx2[1]/46,XX[12]

Monosomies 13, 14, 15, 17

None

25.8

8

Mayo

F

64

31,X, +3, +7, +9, +11, +add(15)(p11.1),add(16)(q12.1), +18, +19, +21[10]/46,XX[10]

Monosomies 13, 14, 15, 17; near-tetraploid

p.Phe270Ser

11.2

9

Mayo

F

49

33,X, +3, +7, +9, +10, +11, +15, +18, +19, +21, +mar[3]/XX[15]

Not performed

NT

9.9

10

Mayo

M

56

31,X,add(1)(q32), +add(3)(q21), +add(5)(q11.2), +7, +9, +11, +15, +18, +del(22)(q13)[19]/46,XY[1]

Not performed

NT

4.2

11

Mayo

M

50

32,X, +3, +5, +7, +9, +11, +15,der(16)t(16;17)(q13;q11.2), +18, +19, +21[5]/46,XY[15]

Monosomies 13, 14, 17

None

4.4

12

Mayo

F

72

33,X, +1, +2, +6, +7, +11, +14, +18, +19, +21, +22[6]/46,XX[7]

Not performed

p.Arg156Pro

75.5

13

Mayo

M

50

31~33,XY, +3, +5, +7, +add(9)(p13), +11, +15, +18, +19, +mar[cp7]/46,XY[3]

Monosomies 13, 14, 17; trisomy 9

NT

6.8

14

Mayo

M

44

34,X, +3, +5, +add(7p22), +9, +10, +11, +15, +18, +19, +add(21)(q22), +mar[6]/46,XY[14]

Monosomies 13, 14, 17

None

45.8

15

Mayo

M

43

34,X, +3, +5, +7, +8, +9, +9, +11, +15, +18, +19, +21[2]/46,XY[28]

Monosomies 13, 14, 17

p.Asp48Alafs*5

NA

16

Mayo

F

80

32,X, +3, +5, +7, +9, +11, +15, +add(15)(p11.2), +19, +21[5]/46,XX[12]

Monosomies 13, 14, 17

p.Pro250Thr

18

17

Mayo

F

53

33,X,der(1;21)(q10;q10), +3, +5, +7, +9, +11, +add(14)(q32), +15, +18, +19, +21[4]/46,XX[16]

Monosomies 4, 6, 13, 16, 17, 20; IGH/MYC fusion

p.Thr253Pro

12.4

18

Mayo

F

71

30,X, +3, +5, +7, +9, +add(11)(q25), +15, +add(19)(q13.3),−21, +1~2mar[cp3]/46,XX[20]

Monosomies 8, 13, 17, 20

p.Tyr220Metfs*27

22.4

19

HHC

F

54

32,X, +der(3)t(2;3)(q33;q29),der(4)inv(4)(p16q13)ins(4;?)(p16;?), +5, +7, +8, +9, +11, +15, +19, +21[3]/46,XX[17]

Monosomies 1, 4, 13, 14, 16, 17

NT

NA

20

HHC

M

53

34,X,del(1)(q11),ins(1;?)(q21;?),add(1)(q32), +der(3)add(3)(p23)add(3)(q22), +add(3)(q22), +5, +7, +8, +9, +11, +add(11)(q23), +14, +add(14)(p11.1), +15, +18, +19, +21[cp20]/46,XY[1]

Not performed

NT

NA

21

HHC

M

58

30,X, +2, +3, +8, +11, +15, +18, +19,−22, +mar[4]/46,XY[3]

Monosomies 1, 4, 13, 14, 16, 17

NT

NA

22

HHC

M

50

33,X, +3, +5, +7, +9, +10, +11, +15, +18, +19, +21[5]/46,XY[15]

Monosomies 1, 4, 13, 14, 16, 17

NT

NA

  1. Mayo, cases from Mayo Clinic Cohort; HHC, cases from Hennepin Health Care
  2. NT not tested; NA Time to death information not available for HHC cases